IP Library Patent Application 13303467
Patent Application
App. No. 13/303,467

METHOD FOR TREATING HEPATITIS C VIRUS INFECTION USING QUERCETIN-CONTAINING COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/303,467
Abstract

A method for treating hepatitis C virus infection with a composition containing quercetin, together with one or more of vitamin B 3 , vitamin C, a folate compound. Also disclosed is a method for treating conditions associated with an elevated level of heat shock proteins, including liver cancer, using the above-mentioned composition.

Claims (22)

1 . A method for treating hepatitis C virus infection, the method comprising administering to a subject in need thereof an effective amount of a composition that includes quercetin and vitamin B3, vitamin C, or a folate compound.

2 . The method of claim 1 , wherein the composition includes vitamin B3.

3 . The method of claim 1 , wherein the composition includes vitamin C.

4 . The method of claim 1 , wherein the composition includes a folate compound.

5 . The method of claim 4 , wherein the folate compound is L-methyl folate.

6 . The method of claim 2 , wherein the composition includes vitamin C.

7 . The method of claim 6 , wherein the composition includes a folate compound.

8 . The method of claim 7 , wherein the folate compound is L-methyl folate.

9 . The method of claim 2 , wherein the composition includes a folate compound.

10 . The method of claim 3 , wherein the composition includes a folate compound.

11 . The method of claim 1 , wherein the composition further includes one or more of genistein, genistin, curcumin, resveratrol, luteolin, epigallocatechin gallate (EGCG), coenzyme Q10, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).

12 . The method of claim 11 , wherein the composition includes luteolin or epigallocatechin gallate (EGCG).

13 . The method of claim 1 , wherein the composition is co-administered with an anti-viral drug.

14 . The method of claim 13 , wherein the anti-viral drug is pegylated interferon alpha, ribavirin, boceprevir, or telaprevir.

15 . A method for treating a disorder associated with an elevated level of a heat shock protein, the method comprising administering to a subject in need thereof an effective amount of a composition that includes quercetin and one or more of vitamin B3, vitamin C, or a folate compound.

16 . The method of claim 15 , wherein the composition includes vitamin B3.

17 . The method of claim 16 , wherein the composition includes vitamin C.

18 . The method of claim 17 , wherein the composition includes a folate compound.

19 . The method of claim 18 , wherein the folate compound is L-methyl folate.

20 . The method of claim 15 , wherein the composition further includes one or more of genistein, genistin, curcumin, resveratrol, luteolin, epigallocatechin gallate (EGCG), coenzyme Q10, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).

21 . The method of claim 20 , wherein the composition includes luteolin or epigallocatechin gallate (EGCG).

22 . The method of claim 15 , wherein the disorder is an autoimmune disease, a vascular disorder, a pregnancy-related disorder, a viral infection, or liver or other cancer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: QUERCEGEN PHARMA A.G.
To: LINES, THOMAS CHRISTIAN
Reel/Frame 052151/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: LINES, THOMAS CHRISTIAN
To: QUERCIS PHARMA A.G.
Reel/Frame 052153/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2020
From: LINES, THOMAS; QUERCEGEN PHARMA LLC; QUERCEGEN PHARMA LLP; QUERCEGEN TECHNOLOGIES; QUERCEGEN PHARMACEUTICALS, LLC; QUERCEGEN HOLDINGS, LLC; NEW SUN NUTRITION, LLC; THE FRS COMPANY
To: QUERCEGEN PHARMA, AG.
Reel/Frame 052110/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2012
From: LINES, THOMAS CHRISTIAN
To: QUERCEGEN PHARMACEUTICALS LLC
Reel/Frame 027898/0960 →